Table 1. Clinical characteristics of AF patients and controls.

	Patients	Controls
	73	20
Gender (male)	43 (59%)	11 (55%)
Age (years)	69.5 ± 9.3	66.8 ± 6.7
Cardiomyopathies	6 (8%)	2 (10%)
Hypertension	50 (68%)	14 (70%)
Diabetes	5 (6%)	1 (5%)
NYHA Class
I	62 (85%)	20 (100%)
II	8 (11%)	–
III	3 (4%)	–
IV	–	–
LVEF (%)	61%	62%
ACE-inhibitors	22 (30%)	8 (40%)
Sartans	12 (6%)	1 (5%)
Betablockers	53 (73%)	6 (30%)
Diuretics	17 (24%)	4 (20%)
Spironolactone	2 (3%)	v
Ca-channel blockers	8 (11%)	3 (15%)
Nitrates	1 (2%)	–
Digitals	1 (2%)	–
Antiplatelets	6 (8%)	7 (35%)
Anticoagulants	61 (84%)	12 (63%)
Antiarrhythmics	41 (56%)	no
Statine	14 (19%)	3 (15%)